Particle.news

Download on the App Store

Colossal Biosciences Achieves Milestone with Birth of Genetically Engineered Dire Wolf Pups

Using advanced cloning and gene-editing techniques, the Dallas-based biotech company has successfully revived the extinct dire wolf species, marking a significant step in de-extinction science.

Image
The first two dire wolves born at Colossal, here shown at the age of one month old.
Image
Romulus and Remus, the first two dire wolf pups created by Colossal Biosciences (Credit: Colossal Biosciences)

Overview

  • Three dire wolf pups—Romulus, Remus, and Khaleesi—were created using ancient DNA and genetic material from gray wolves, with the births announced on April 8, 2025.
  • Colossal Biosciences utilized a novel gene-editing process to modify 14 genes in gray wolf cells, replicating 20 key traits of dire wolves, including size, coat color, and vocalizations.
  • The embryos were implanted into domestic hound surrogates, resulting in successful cesarean births without complications for the surrogate mothers.
  • The company plans to apply similar techniques to revive the woolly mammoth by 2028, with surrogate elephant pregnancies projected to begin by 2026.
  • In addition to de-extinction, Colossal is leveraging its genetic technologies to address biodiversity challenges, such as combating genetic bottlenecks in endangered species like the pink pigeon and red wolf.